Medical imaging and neurointerventional device markets projected to grow through 2035

Recent market research from SNS Insider indicates significant growth in specialized medical device sectors, specifically neurointerventional devices and intracardiac echocardiography (ICE).

The neurointerventional device market is expected to grow from $2.82 billion in 2025 to $4.48 billion by 2035, representing a compound annual growth rate (CAGR) of 4.7%. This expansion is driven by the increasing demand for minimally invasive treatments for ischemic stroke, intracranial aneurysms, and other cerebrovascular diseases. Embolization coils currently hold the largest market share, while stent retrievers are identified as the fastest-growing segment. North America, led by the United States, remains the dominant region.

Simultaneously, the intracardiac echocardiography (ICE) market is projected to rise from $1.42 billion in 2025 to $3.05 billion by 2035, with a CAGR of 8.0%. The growth is fueled by advancements in catheter ablation for atrial fibrillation and transcatheter treatments for structural heart diseases. ICE catheters are the primary product segment, while 3D/4D imaging technology is expected to see high growth rates as clinicians seek more precise anatomical visualization during procedures.